Erschienen in:
23.03.2022 | Surgery and Surgical Innovations in Colorectal Cancer (M Al-Kasspooles, Section Editor)
Liver-Directed Therapy for Metastatic Colon Cancer: Update
verfasst von:
John J. Waddell, Patricia H. Townsend, Zachary S. Collins, Carissa Walter
Erschienen in:
Current Colorectal Cancer Reports
|
Ausgabe 1/2022
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
To discuss the emerging technologies in the field of Interventional radiology (IR) for the management of metastatic colorectal cancer (mCRC). We review the field of selective internal radiation therapy (SIRT), and well-known IR treatments, with a more focused investigation of radioembolization with Yttrium-90 (Y-90).
Recent Findings
State-of-the-art treatment modalities for unresectable hepatic malignancies are crucial to increased patient survival. There are many options for the treating physician to manage and potentially cure patient’s disease, with Y-90 as the cornerstone of liver neoplasm treatment. Additionally, current research in the fields of dosimetry and radiomics may allow for more optimized patient specific radiation doses.
Summary
Continued advancements in colorectal surgery and interventional radiology have improved survival outcomes for patients with mCRC. Current treatment options are numerous and often include partial hepatectomy and SIRT. We review current literature and discuss our experiences in treating patients with advanced liver malignancies.